Patent · US Active

Combined use of ribonuclease and artemisinin

US8986683B2 · kind B2 · utility

0Cited by

0References

8Claims

0Family size

Assignees

Shanghai Biomodel Organism Science & Technology Co., Ltd. · CN
Shanghai Research Center for Model Organisms · CN

Inventors

Qingcheng Wang · Shanghai, CN
Ruling Shen · Shanghai, CN
Jun Li · Miaocheng, CN
Jian Fei · Shanghai, CN
Zhugang Wang · Shanghai, CN

Key dates

Filing date	Sep 10, 2012
Grant date	Mar 24, 2015
Priority date	—
Expiry date	Dec 29, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2501/70
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention discloses a kit which comprises a formulation containing artemisinin or the derivatives thereof, a formulation containing ribonuclease, and a specification.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.